Nuclear Translocation of Nuclear Transcription Factor-κB by α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors Leads to Transcription of p53 and Cell Death in Dopaminergic Neurons

We describe a new molecular mechanism of cell death by excitotoxicity mediated through nuclear transcription factor kappa B (NF kappa B) in rat embryonic cultures of dopaminergic neurons. Treatment of mesencephalic cultures with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) resulted in a number of changes that occurred selectively in dopaminergic neurons, including persistent elevation in intracellular Ca(2+) monitored with Fura-2, and a significant increase in intramitochondrial oxidation of dihydrorhodamine 123, probably associated with transient increase of mitochondrial permeability, cytochrome c release, nuclear translocation of NF kappa B, and transcriptional activation of the oncogene p53. Interruption of any of these steps by specific antagonists prevented neurite pruning and programmed cell death. In contrast, cell death was not prevented by caspase antagonists and only partly prevented by nitric-oxide synthase inhibitors. This signal transduction pathway might be a contributing mechanism in ongoing neuronal death in Parkinson disease.

• Publication year

  2003

• Venue

  Molecular Pharmacology

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/MOL.63.4.784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Physiology and Anatomy of Possible Oscillators in the Central Nervous System

  2008cited by this paper
• Mitochondria, the killer organelles and their weapons

  2002influential reference
• FADD: A link between TNF family receptors and caspases in Parkinson’s disease

  2002cited by this paper
• Proteasomal function is impaired in substantia nigra in Parkinson's disease.

  2001cited by this paper
• Role of NF-kappaB in p53-mediated programmed cell death.

  2000cited by this paper
• Cyclosporin A targets involved in protection against glutamate excitotoxicity.

  2000cited by this paper
• Death signaling pathway induced by pyrrolidine dithiocarbamate‐Cu2+ complex in the cultured rat cortical astrocytes

  2000influential reference
• Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF‐κb, and MAP kinases

  2000cited by this paper
• Role of NF-κB in p53-mediated programmed cell death

  2000cited by this paper
• Roles of Nuclear Factor κB in Neuronal Survival and Plasticity

  2000cited by this paper
• Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(2+) and Zn(2+).

  2000cited by this paper
• Differential vulnerabilities of substantia nigra catecholamine neurons to excitatory amino acid-induced degeneration in rat midbrain slices.

  2000cited by this paper
• Roles of nuclear factor kappaB in neuronal survival and plasticity.

  2000cited by this paper
• Interaction Among Mitochondria, Mitogen‐Activated Protein Kinases, and Nuclear Factor‐κB in Cellular Models of Parkinson's Disease

  2000cited by this paper
• Blockade of the Mitochondrial Permeability Transition Pore Diminishes Infarct Size in the Rat after Transient Middle Cerebral Artery Occlusion

  1999cited by this paper
• The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

  1999cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

  1999cited by this paper
• Prospects for new restorative and neuroprotective treatments in Parkinson's disease

  1999cited by this paper
• NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

  1999cited by this paper
• Cyclosporin A and its nonimmunosuppressive analogue N‐Me‐Val‐4‐cyclosporin A mitigate glucose/oxygen deprivation‐induced damage to rat cultured hippocampal neurons

  1999cited by this paper
• Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain

  1999cited by this paper
• From entropy to Duino

  1999cited by this paper
• Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity.

  1998cited by this paper
• Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotection

  1998cited by this paper
• Oxidative mechanisms in nigral cell death in Parkinson's disease.

  1998cited by this paper
• Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

  1997cited by this paper
• Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

  1997influential reference
• Calcineurin and mitochondrial function in glutamate‐induced neuronal cell death

  1996cited by this paper
• Histochemical detection of apoptosis in Parkinson's disease.

  1996cited by this paper
• Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons

  1996cited by this paper
• Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures.

  1996influential reference
• A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

  1995cited by this paper
• Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons.

  1995cited by this paper
• Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate

  1995cited by this paper
• Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.

  1995cited by this paper
• Persistent AMPA receptor stimulation alters [Ca2+]i homeostasis in cultures of embryonic dopaminergic neurons.

  1994influential reference
• Iron and ferritin in substantia nigra in Parkinson's disease.

  1993cited by this paper
• Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a

  1992cited by this paper
• K(+)-evoked dopamine release depends on a cytosolic Ca2+ pool regulated by N-type Ca2+ channels.

  1992cited by this paper
• Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis

  1991cited by this paper
• 5,7-Dihydroxytryptamine identifies living dopaminergic neurons in mesencephalic cultures.

  1988cited by this paper

• In silico prediction of the impact of genomic variations in the small conductance calcium activated potassium channel SK3 structure and function

  2025cites this paper
• Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases

  2022cites this paper
• COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress †

  2020cites this paper
• PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats

  2020cites this paper
• Age-dependent neuroprotective effect of an SK3 channel agonist on excitotoxity to dopaminergic neurons in organotypic culture

  2019cites this paper
• Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease

  2019cites this paper
• Activation inhibitors of nuclear factor kappa B protect neurons against the NMDA-induced damage in the rat retina.

  2017cites this paper
• The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease

  2016cites this paper
• Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP)

  2015cites this paper
• Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population.

  2015cites this paper
• Examining the impact of caspase activities in PD animal model & differentiated ReNcell VM

  2015cites this paper
• Effects of Two Commonly Found Strains of Influenza A Virus on Developing Dopaminergic Neurons, in Relation to the Pathophysiology of Schizophrenia

  2012cites this paper
• p38 Mitogen-activated Protein Kinase and Nuclear Factor-κB Facilitate CD40-mediated Salivary Epithelial Cell Death

  2012cites this paper
• α-Synuclein Negatively Regulates Protein Kinase Cδ Expression to Suppress Apoptosis in Dopaminergic Neurons by Reducing p300 Histone Acetyltransferase Activity

  2011cites this paper
• Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

  2011influential citation
• Molecular and cellular mechanisms of excitotoxic neuronal death

  2010cites this paper
• IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase

  2009cites this paper
• Glutamate-induced NFkappaB activation in the retina.

  2009cites this paper
• The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells.

  2008cites this paper
• PARP activation and inflammatory reaction in selective neurodegeneration.

  2008cites this paper
• Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapy

  2007cites this paper
• Distinct destructive signal pathways of neuronal death in Alzheimer's disease.

  2006cites this paper
• Ultrastructural characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced cell death in embryonic dopaminergic neurons

  2006cites this paper
• The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5).

  2006cites this paper
• A possible regulation of Alzheimer's disease

  2006cites this paper
• Implication of calpain in neuronal apoptosis

  2006cites this paper
• Glutamate activation of Oct‐2 in cultured chick Bergmann glia cells: Involvement of NFκB

  2005cites this paper
• Distinct nuclear factor-κB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells

  2005cites this paper
• Signaling via NF-?B in the nervous system

  2005cites this paper
• Neuronal Activation of NF-κB Contributes to Cell Death in Cerebral Ischemia

  2005cites this paper
• A simplified probe preparation for ELISA-based NF-κB activity assay

  2005cites this paper
• Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration

  2004cites this paper
• The role of NF-κB in 6-hydroxydopamine- and TNFα-induced apoptosis of PC12 cells

  2004cites this paper
• Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB*

  2004cites this paper
• The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease

  2004cites this paper
• Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant.

  2004cites this paper
• Glutamate activates NF‐κB through calpain in neurons

  2003cites this paper
• Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

  2003cites this paper